TrilliumBiO and Oncobit Launch Advanced Uveal Melanoma Monitoring Solution in the U.S.

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

TrilliumBiO-Oncobit

More Like This

PR Newswire associated0

TrilliumBiO and Oncobit Partner to Bring Novel Uveal Melanoma Monitoring Solution to the U.S.

Tracer Biotechnologies Announces Agreement for Next-Generation Cancer Monitoring for Drug Development

Jo Gumbs, CEO and Founder of Ocular Melanoma UK

Groundbreaking Treatment for Metastatic Uveal Melanoma Approved for Use in the UK

PR Newswire associated0

Menarini Silicon Biosystems announces new study results on use of CELLSEARCH® liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma

Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications

Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized bladder cancer care pathway

Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025

Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions